In immunocompromised mice, insulin-like growth factor 1-coated sutures and systemic insulin-like growth factor-1 administration have been shown to improve anastomotic strength and hydroxyproline content in a mouse model of colitis [34,35]. The gene discussed is IGF1; the disease is colitis.